TwinBeech Capital’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$816K Buy
+106,377
New +$1.04M 0.19% 154
2026
Q1
– Sell
-140,350
Closed -$1.7M – 754
2025
Q4
$1.7M Buy
140,350
+77,504
+123% +$941K 0.12% 218
2025
Q3
$735K Buy
+62,846
New +$752K 0.03% 352
2021
Q3
– Sell
-13,311
Closed -$189K – 709
2021
Q2
$189K Buy
+13,311
New +$202K 0.02% 418

Other funds holding OCUL

TwinBeech Capital's OCUL Position: Q3 2026 in Review

TwinBeech Capital opened a new position in Ocular Therapeutix (OCUL) in Q3 2026: 106,377 shares worth $816K. The stake represents 0.19% of the portfolio and ranks #154 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in OCUL as recently as Q4 2025.

TwinBeech Capital first reported a position in OCUL in Q2 2021 and has held it in 4 quarters since. The position peaked at $1.7M in Q4 2025. 258 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • TwinBeech Capital held 106,377 shares of Ocular Therapeutix worth $816K as of Q3 2026.
  • Ocular Therapeutix was a new TwinBeech Capital position in Q3 2026.
  • Ocular Therapeutix made up 0.19% of TwinBeech Capital's portfolio in Q3 2026, its #154 holding.
  • TwinBeech Capital first reported a position in Ocular Therapeutix in Q2 2021 and has held it in 4 quarters since.
  • TwinBeech Capital's Ocular Therapeutix position peaked at $1.7M in Q4 2025.
  • 258 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.